AKAP79 enables calcineurin to directly suppress protein kinase A activity

  1. Timothy W Church
  2. Parul Tewatia
  3. Saad Hannan
  4. João Antunes
  5. Olivia Eriksson
  6. Trevor G Smart
  7. Jeanette Hellgren Kotaleski
  8. Matthew G Gold  Is a corresponding author
  1. University College London, United Kingdom
  2. KTH Royal Institute of Technology, Sweden

Abstract

Interplay between the second messengers cAMP and Ca2+ is a hallmark of dynamic cellular processes. A common motif is the opposition of the Ca2+-sensitive phosphatase calcineurin and the major cAMP receptor, protein kinase A (PKA). Calcineurin dephosphorylates sites primed by PKA to bring about changes including synaptic long-term depression (LTD). AKAP79 supports signaling of this type by anchoring PKA and calcineurin in tandem. In this study, we discovered that AKAP79 increases the rate of calcineurin dephosphorylation of type II PKA regulatory subunits by an order of magnitude. Fluorescent PKA activity reporter assays, supported by kinetic modeling, show how AKAP79-enhanced calcineurin activity enables suppression of PKA without altering cAMP levels by increasing PKA catalytic subunit capture rate. Experiments with hippocampal neurons indicate that this mechanism contributes towards LTD. This non-canonical mode of PKA regulation may underlie many other cellular processes.

Data availability

Source data files have been provided for figures 1-6, figure 1-supplement 2, figure 1-supplement 3, figure 3-supplement 1, and figure 3-supplement 2.Original images an uncrossed images for Coomassie-stained gels and immunoblots presented in the manuscript are shown in the zipped folder provided as an additional file.A code repository for this study may be accessed at https://github.com/jdgas/AKAP79_PKA. It contains the R code for the ABC method as well as MATLAB code for reproducing figures. The R code has to be run on a computer cluster. The repository also contains the models with a few example parameter sets, the full parameter sample as described above, and supplementary figures with simulations and experimental data for all 0, 0.2, 1 and 2 M cAMP levels with either WT S98A, or S98E RII𝛼 in the reaction mix.

Article and author information

Author details

  1. Timothy W Church

    Neuroscience, Physiology & Pharmacology, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5958-6304
  2. Parul Tewatia

    Science of Life Laboratory, School of Computer Science and Communication, KTH Royal Institute of Technology, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  3. Saad Hannan

    Neuroscience, Physiology and Pharmacology, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4594-0808
  4. João Antunes

    Science of Life Laboratory, School of Computer Science and Communication, KTH Royal Institute of Technology, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9635-5145
  5. Olivia Eriksson

    Science of Life Laboratory, School of Computer Science and Communication, KTH Royal Institute of Technology, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0740-4318
  6. Trevor G Smart

    Neuroscience, Physiology and Pharmacology, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9089-5375
  7. Jeanette Hellgren Kotaleski

    Science of Life Laboratory, School of Computer Science and Communication, KTH Royal Institute of Technology, Stockholm, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0550-0739
  8. Matthew G Gold

    Neuroscience, Physiology & Pharmacology, University College London, London, United Kingdom
    For correspondence
    m.gold@ucl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1281-0815

Funding

Wellcome Trust and Royal Society (104194/Z/14/A)

  • Matthew G Gold

BBSRC (BB/N015274/1)

  • Matthew G Gold

Swedish Research Council (VR-M-2017-02806)

  • Matthew G Gold

European Union/Horizon 2020 (945539 Human Brain Project SGA3)

  • Matthew G Gold

Erasmus Scholarship

  • João Antunes

Wellcome Trust (217199/Z/19/Z)

  • Saad Hannan
  • Trevor G Smart

Swedish Research Council (VR-M-2020-01652)

  • Matthew G Gold

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Amy Andreotti, Iowa State University, United States

Ethics

Animal experimentation: Experiments involving rats were done in accordance with the United Kingdom Animals Act, 1986 and within University College London Animal Research guidelines overseen by the UCL Animal Welfare and Ethical Review Body under project code 14058.

Version history

  1. Received: March 7, 2021
  2. Preprint posted: March 15, 2021 (view preprint)
  3. Accepted: October 4, 2021
  4. Accepted Manuscript published: October 6, 2021 (version 1)
  5. Version of Record published: November 1, 2021 (version 2)

Copyright

© 2021, Church et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,673
    Page views
  • 242
    Downloads
  • 5
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Timothy W Church
  2. Parul Tewatia
  3. Saad Hannan
  4. João Antunes
  5. Olivia Eriksson
  6. Trevor G Smart
  7. Jeanette Hellgren Kotaleski
  8. Matthew G Gold
(2021)
AKAP79 enables calcineurin to directly suppress protein kinase A activity
eLife 10:e68164.
https://doi.org/10.7554/eLife.68164

Share this article

https://doi.org/10.7554/eLife.68164

Further reading

    1. Biochemistry and Chemical Biology
    Jake W Anderson, David Vaisar ... Natalie G Ahn
    Research Article

    Activation of the extracellular signal-regulated kinase-2 (ERK2) by phosphorylation has been shown to involve changes in protein dynamics, as determined by hydrogen-deuterium exchange mass spectrometry (HDX-MS) and NMR relaxation dispersion measurements. These can be described by a global exchange between two conformational states of the active kinase, named ‘L’ and ‘R,’ where R is associated with a catalytically productive ATP-binding mode. An ATP-competitive ERK1/2 inhibitor, Vertex-11e, has properties of conformation selection for the R-state, revealing movements of the activation loop that are allosterically coupled to the kinase active site. However, the features of inhibitors important for R-state selection are unknown. Here, we survey a panel of ATP-competitive ERK inhibitors using HDX-MS and NMR and identify 14 new molecules with properties of R-state selection. They reveal effects propagated to distal regions in the P+1 and helix αF segments surrounding the activation loop, as well as helix αL16. Crystal structures of inhibitor complexes with ERK2 reveal systematic shifts in the Gly loop and helix αC, mediated by a Tyr-Tyr ring stacking interaction and the conserved Lys-Glu salt bridge. The findings suggest a model for the R-state involving small movements in the N-lobe that promote compactness within the kinase active site and alter mobility surrounding the activation loop. Such properties of conformation selection might be exploited to modulate the protein docking interface used by ERK substrates and effectors.

    1. Biochemistry and Chemical Biology
    Anne E Hultgren, Nicole MF Patras, Jenna Hicks
    Feature Article

    Organizations that fund research are keen to ensure that their grant selection processes are fair and equitable for all applicants. In 2020, the Arnold and Mabel Beckman Foundation introduced blinding to the first stage of the process used to review applications for Beckman Young Investigator (BYI) awards: applicants were instructed to blind the technical proposal in their initial Letter of Intent by omitting their name, gender, gender-identifying pronouns, and institutional information. Here we examine the impact of this change by comparing the data on gender and institutional prestige of the applicants in the first four years of the new policy (BYI award years 2021–2024) with data on the last four years of the old policy (2017–2020). We find that under the new policy, the distribution of applicants invited to submit a full application shifted from those affiliated with institutions regarded as more prestigious to those outside of this group, and that this trend continued through to the final program awards. We did not find evidence of a shift in the distribution of applicants with respect to gender.